Ketamine Completed Phase 0 Trials for Major Depressive Disorder (MDD) Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science0
clinicaltrials.gov IdentifierTitleDrugs
NCT03609190A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine